665 related articles for article (PubMed ID: 16595794)
1. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
[TBL] [Abstract][Full Text] [Related]
2. Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions.
Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Pérez-Molino A; Hebbel RP; Nguyen J; Bernabéu C; Botella LM
Cardiovasc Res; 2005 Nov; 68(2):235-48. PubMed ID: 15993872
[TBL] [Abstract][Full Text] [Related]
3. ALK5- and TGFBR2-independent role of ALK1 in the pathogenesis of hereditary hemorrhagic telangiectasia type 2.
Park SO; Lee YJ; Seki T; Hong KH; Fliess N; Jiang Z; Park A; Wu X; Kaartinen V; Roman BL; Oh SP
Blood; 2008 Jan; 111(2):633-42. PubMed ID: 17911384
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressor FK506 increases endoglin and activin receptor-like kinase 1 expression and modulates transforming growth factor-β1 signaling in endothelial cells.
Albiñana V; Sanz-Rodríguez F; Recio-Poveda L; Bernabéu C; Botella LM
Mol Pharmacol; 2011 May; 79(5):833-43. PubMed ID: 21310938
[TBL] [Abstract][Full Text] [Related]
5. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells.
Albiñana V; Bernabeu-Herrero ME; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2010 Mar; 103(3):525-34. PubMed ID: 20135064
[TBL] [Abstract][Full Text] [Related]
6. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia.
Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C
Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572
[TBL] [Abstract][Full Text] [Related]
7. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia.
Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K
Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364
[TBL] [Abstract][Full Text] [Related]
8. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease.
Abdalla SA; Letarte M
J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500
[TBL] [Abstract][Full Text] [Related]
9. Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia.
Albiñana V; Recio-Poveda L; Zarrabeitia R; Bernabéu C; Botella LM
Thromb Haemost; 2012 Jul; 108(1):41-53. PubMed ID: 22552254
[TBL] [Abstract][Full Text] [Related]
10. Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.
Lebrin F; Goumans MJ; Jonker L; Carvalho RL; Valdimarsdottir G; Thorikay M; Mummery C; Arthur HM; ten Dijke P
EMBO J; 2004 Oct; 23(20):4018-28. PubMed ID: 15385967
[TBL] [Abstract][Full Text] [Related]
11. Hereditary haemorrhagic telangiectasia: a questionnaire based study to delineate the different phenotypes caused by endoglin and ALK1 mutations.
Berg J; Porteous M; Reinhardt D; Gallione C; Holloway S; Umasunthar T; Lux A; McKinnon W; Marchuk D; Guttmacher A
J Med Genet; 2003 Aug; 40(8):585-90. PubMed ID: 12920067
[TBL] [Abstract][Full Text] [Related]
12. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Pericacho M; Rodriguez-Barbero A; Eleno N; Lopez-Novoa JM; Düwell A; Vega MA; Bernabeu C; Botella LM
Hum Mol Genet; 2007 Jul; 16(13):1515-33. PubMed ID: 17420163
[TBL] [Abstract][Full Text] [Related]
13. Hereditary haemorrhagic telangiectasia: a clinical and scientific review.
Govani FS; Shovlin CL
Eur J Hum Genet; 2009 Jul; 17(7):860-71. PubMed ID: 19337313
[TBL] [Abstract][Full Text] [Related]
14. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia.
Lebrin F; Mummery CL
Trends Cardiovasc Med; 2008 Jan; 18(1):25-32. PubMed ID: 18206806
[TBL] [Abstract][Full Text] [Related]
15. Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia and expression analysis of Endoglin and ALK1.
Fernandez-L A; Sanz-Rodriguez F; Zarrabeitia R; Perez-Molino A; Morales C; Restrepo CM; Ramirez JR; Coto E; Lenato GM; Bernabeu C; Botella LM
Hum Mutat; 2006 Mar; 27(3):295. PubMed ID: 16470589
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic analyses of three Korean families with hereditary hemorrhagic telangiectasia.
Kim MJ; Kim ST; Lee HD; Lee KY; Seo J; Lee JB; Lee YJ; Oh SP
BMC Med Genet; 2011 Oct; 12():130. PubMed ID: 21967607
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Activin Receptor-Like Kinase 1 in Endothelial Cells Suppresses Development of Arteriovenous Malformations in Mouse Models of Hereditary Hemorrhagic Telangiectasia.
Hwan Kim Y; Vu PN; Choe SW; Jeon CJ; Arthur HM; Vary CPH; Lee YJ; Oh SP
Circ Res; 2020 Oct; 127(9):1122-1137. PubMed ID: 32762495
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta receptor function in the endothelium.
Lebrin F; Deckers M; Bertolino P; Ten Dijke P
Cardiovasc Res; 2005 Feb; 65(3):599-608. PubMed ID: 15664386
[TBL] [Abstract][Full Text] [Related]
19. MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells.
Tabruyn SP; Hansen S; Ojeda-Fernández ML; Bovy N; Zarrabeitia R; Recio-Poveda L; Bernabéu C; Martial JA; Botella LM; Struman I
Angiogenesis; 2013 Oct; 16(4):877-87. PubMed ID: 23800974
[TBL] [Abstract][Full Text] [Related]
20. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.
Oh SP; Seki T; Goss KA; Imamura T; Yi Y; Donahoe PK; Li L; Miyazono K; ten Dijke P; Kim S; Li E
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2626-31. PubMed ID: 10716993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
